Old Web
English
Sign In
Acemap
>
authorDetail
>
Michael S van der Veer
Michael S van der Veer
VU University Medical Center
Medicine
Antibody
CD20
Rituximab
Bortezomib
2
Papers
21
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Overcoming bortezomib resistance in human B cells by anti-CD20/rituximab-mediated complement-dependent cytotoxicity and epoxyketone-based irreversible proteasome inhibitors
2013
Experimental hematology & oncology
Sue Ellen Verbrugge
Marjon Al
Yehuda G. Assaraf
Denise Niewerth
Johan van Meerloo
Jacqueline Cloos
Michael S van der Veer
George L. Scheffer
Godefridus J. Peters
Elena T. Chan
Janet L. Anderl
Christopher J. Kirk
Sonja Zweegman
Ben A. C. Dijkmans
Willem F. Lems
Rik J. Scheper
Tanja D. de Gruijl
Gerrit Jansen
Show All
Source
Cite
Save
Citations (18)
In Vitro and In Vivo Efficacy of CD38 Directed Therapy with Daratumumab In the Treatment of Multiple Myeloma
2010
Blood
Richard W.J. Groen
Michael S van der Veer
Frans M. A. Hofhuis
Berris van Kessel
Michel de Weers
Paul W. H. I. Parren
Henk M. Lokhorst
Tuna Mutis
Anton C.M. Martens
Show All
Source
Cite
Save
Citations (3)
1